缬沙坦联合氨氯地平治疗原发性高血压伴左心室肥厚临床疗效.docVIP

缬沙坦联合氨氯地平治疗原发性高血压伴左心室肥厚临床疗效.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
缬沙坦联合氨氯地平治疗原发性高血压伴左心室肥厚临床疗效

缬沙坦联合氨氯地平治疗原发性高血压伴左心室肥厚临床疗效   [摘要] 目的 探讨缬沙坦联合氨氯地平治疗高血压伴左心肥厚的临床疗效和对患者心功能的影响。 方法 将我院收治的原发性高血压伴左心室肥厚患者64例给予缬沙坦联合氨氯地平治疗,患者口服缬沙坦80 mg/d,氨氯地平5 mg/d,第2周后根据患者情况调整至缬沙坦160 mg/d,氨氯地平10 mg/d,疗程6周。监测患者血压变化,采用超声心动图监测治疗前后患者左心室舒张末期内径(LVDd)、舒张末期室间隔厚度(IVSd)、左室射血分数(LVEF)、每搏输出量(SV)、每分输出量(CO)变化。 结果 治疗后患者血压明显降低(P < 0.05),总有效率为92.19%;治疗后患者LVDd、IVSd较治疗前降低,LVEF、SV、CO较治疗前升高,与治疗前比较差异有统计学意义(P < 0.05)。 结论 缬沙坦联合氨氯地平可以有效降低高血压患者血压,改善患者左心室肥厚和心功能。   [关键词] 高血压;缬沙坦;氨氯地平;心功能   [中图分类号] R544.1 [文献标识码] A [文章编号] 1673-7210(2012)04(a)-0087-02      Clinical efficacy of Valsartan combined with Amlodipine in the treatment of primary hypertension complicated by left ventricular hypertrophy   JIANG Zhiping HUANG Jinshi   Department of Cardiology, Yuebei Peoples Hospital, Guangdong Province, Shaoguan 512026, China   [Abstract] Objective To investigate the clinical efficacy of Valsartan combined with Amlodipine in the treatment of primary hypertension complicated by left ventricular hypertrophy and its influence on the cardiac function of patients. Methods Sixty-four patients with primary hypertension complicated by left ventricular hypertrophy admitted to our hospital were given the treatment of Valsartan combined with Amlodipine. The patients were administrated with Valsartan 80 mg/d Amlodipine 5mg/d. In the second week, according to the patients conditions, the dosage was adjusted to Valsartan 160 mg/d and Amlodipine 10 mg/d for 6 weeks. The blood pressure changes of patients were monitored. The changes of left ventricular end-diastolic dimension (LVDd), interventricular septum in diastole (IVSd), left ventricular ejection fraction (LVEF), stroke volume (SV) and cardiac output (CO) of patients before and after treatment were monitored using the echocardiography. Results After treatment, the patients blood pressure decreased significantly (P < 0.05), with the total effective rate of 92.19%; after treatment, the patients LVDd and IVSd were lower than those before treatment, while LVEF, SV and CO were high

文档评论(0)

bokegood + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档